Late-breaking abstract at SUO: Novel oncolytic immunotherapy shows promise for patients with bladder cancer
ROCHESTER, Minn. — A Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the 2024 Society of Urologic Oncology Annual Meeting in Dallas, Dec. 4-6. The study demonstrated a potentially effective treatment for patients with bladder cancer who no longer respond to the common therapy, Bacillus Calmette-Guérin (BCG). The novel […]